Calcium chloride 14.7% solution for injection 5ml ampoules

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

Calcium chloride dihydrate

Inapatikana kutoka:

Martindale Pharmaceuticals Ltd

ATC kanuni:

B05XA07

INN (Jina la Kimataifa):

Calcium chloride dihydrate

Kipimo:

147mg/1ml

Dawa fomu:

Solution for injection

Njia ya uendeshaji:

Intravenous

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 09050101; GTIN: 5014124170162

Taarifa za kipeperushi

IF YOU ARE GIVEN MORE CALCIUM CHLORIDE INJECTION THAN YOU
SHOULD
As this medicine will be given to you whilst you are in hospital, it
is unlikely that you will be given too little or too much. However, if
you think you have been given too much of this medicine, please
tell your doctor or nurse.
The signs of an overdose may be reduced appetite, feeling sick,
being sick, constipation, muscle weakness, mental disturbances,
feeling thirsty, urinate a lot, pain in your bones or kidney pain. In
severe cases it could lead to your heart not beating properly and
you could go into a coma.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Calcium Chloride Injection can cause side
effects, although not everybody gets them.
Possible side effects include:
• dizziness
• drowsiness
• hot flushes
• irregular heartbeat
• low blood pressure
• feeling sick (nausea)
• being sick (vomiting)
• sweating
• tingling sensations
• stomach problems
• irritation in the injected vein
• severe constipation
• loss of appetite
• a metallic taste in the mouth
• dry mouth and thirst
• tiredness
• muscle weakness
• confusion
• high blood pressure
• blood clot within the vein
• muscle or bone pain
• increase in the amount of urine passed
• calcium deposits in the kidney
• kidney stones
Severe and sometimes fatal side effects have been seen in
newborn babies if they have been given Calcium and Ceftriaxone.
If any of the side effects get serious or you notice any side effects
not listed in this leaflet, please tell your doctor.
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. You can also report side effects directly via Yellow Card
Scheme. Website: www.mhra.gov.uk/yellowcard or search for
MHRA Yellow Card in the Google Play or Apple App Store. By
reporting side effects, you can help provide more information on
the safety of this medicine.
PACKAGE LEAFLET: INFORMATION FOR THE USER
D04002
Calciu

Tabia za bidhaa

OBJECT 1
CALCIUM CHLORIDE INJECTION 10 MILLIMOLES IN 10
ML
Summary of Product Characteristics Updated 29-Mar-2018 | Martindale
Pharma
1. Name of the medicinal product
Calcium Chloride 10 millimoles in 10 ml Injection
2. Qualitative and quantitative composition
Calcium Chloride, Dihydrate 14.7% w/v
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Injection
Clear, bright, colourless liquid. Free from visible particulates.
4. Clinical particulars
4.1 Therapeutic indications
Hypocalcaemia or electrolyte imbalance
4.2 Posology and method of administration
Posology
For slow intravenous injection or, after dilution with at least 4
times its volume of Sodium Chloride
Intravenous Infusion (0.9% w/v), by intravenous infusion.
Adults and the elderly
The precise dosage is determined by the requirements of the patient.
Plasma Calcium must be monitored.
An initial injection or infusion of up to 10 millimoles (at a rate not
exceeding 1 millimole per minute)
may be given. This may be continued by infusion of up to 10 millimoles
per day.
Paediatric population
The precise dosage is determined by a paediatrician and is dependent
on the requirements of the patient.
Plasma calcium must be monitored.
Age 2 to 12 years
0.5 millimoles to 3.5 millimoles by intravenous infusion after
dilution with at least 4 times its volume of
Sodium Chloride Intravenous Infusion 0.9% w/v). The dose may be
repeated everyone to three days.
Age: under 2 years
Less than 0.5 millimoles by intravenous infusion after dilution with
at least 4 times its volume of Sodium
Chloride Intravenous Infusion (0.9% w/v). The dose may be repeated
every one to three days.
Method of administration
Intravenous injection or Infusion
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1
Calcium chloride is also contraindicated in those patients with
conditions associated with hypercalcaemia
and hypercalcuria (e.g. some forms of malignant disease) or in those
with conditions associated with
elevat